Latest PEG ratio for Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War): -1.58 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-1.58
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, ORIAU shows a PEG ratio of -1.58. That is below the sector sector average of 3.69. Scroll down for historical charts and peer comparison views.
The its sector sector average PEG ratio is about 3.69. Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is at -1.58, which is lower that average. That is roughly 142.9% below the sector mean. Use the comparison chart on this page to see how ORIAU stacks up against individual peers as well.
Investors watch ORIAU's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s latest reading is -1.58. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently -1.58) with ownership activity and broader fundamentals.